The colony-stimulating factor-1 receptor and focal adhesion kinase offer a unique opportunity to mitigate tumor immune escape and enhance the efficacy of immunotherapy and conventional cytotoxic therapy by reprogramming the tumor microenvironment (46). The gene discussed is CSF1R; the disease is neoplasm.